True Reasons Behind Pfizer's $100B AstraZeneca Bid

True Reasons Behind Pfizer's $100B AstraZeneca Bid Play

April 28 (Bloomberg) –- Wibb Securities President Steve Brozak and Bloomberg’s Shannon Pettypiece discuss Pfizer’s bid for AstraZeneca. They speak with Pimm Fox on Bloomberg Television’s “Taking Stock.” (Source: Bloomberg)

  • On Air Now

    PAID PROGRAMMING Watch Now

  • Next

    PAID PROGRAMMING

blog comments powered by Disqus